TP53 and cancer: It confirms that TP53 is the predominant gene, with mutations across many cancers and partially showing the mutual exclusivity of key driver mutations.34,35 Second, we performed a pan-cancer differential expression analysis across all TCGA cancer types against adjacent normal samples, showing the distribution of fold change across multiple cancer types for genes that are consistently up- and downregulated in cancer (Fig 3).